Menu

Telix Pharmaceuticals Limited TLX

Full chart Compare
Set alert

Price alert · TLX

All alert types
9.63 USD +0.21 (+2.23%)

At closeNov 6, 2026, 4:00 PM EST

9.63 0.00 0.00%

After hours · Nov 6, 4:00 PM ET

9.42 Day range 9.71
6.41 52-week range 12.83
YTD
+28.57%
1 year
-2.53%

Revenue & Expenses

Revenue by
United States → Revenue: $784.90MRevenue → Gross Profit: $419.47MGross Profit → Expenses: $419.47MRevenue → Cost of Revenue: $370.31MExpenses → Selling, General & Admin: $233.75MExpenses → Research & Development: $168.26MExpenses → Other Expenses: $22.63MExpenses → Income Tax: $1.83MNet Loss → Expenses: $7.00MChina → Revenue: $9.83MGross Profit$419.47MNet Loss$7.00MCost of Revenue$370.31MExpenses$426.47MSelling, General & Admin$233.75MResearch & Development$168.26MOther Expenses$22.63MIncome Tax$1.83MRevenue$789.77MUnited States$784.90MChina$9.83M

Latest period ending Dec 31, 2025 · select a line to chart its full history

TLX annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022
803.79M516.55M332.98M160.10M
426.44M336.16M209.53M94.93M
29.78M55.18M11.01M-91.93M
-7.13M33.69M4.21M-104.08M
TLX annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022
141.87M440.00M84.30M116.33M
1.16B940.38M277.26M255.35M
748.61M587.44M174.61M175.35M
467.11M360.16M12.26M10.45M
415.38M352.94M102.64M80.01M
TLX annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022
-17.29M27.49M14.27M-63.97M
-285.92M-86.69M-16.84M-17.00M
-3.72M416.79M7.09M174.96M
-25.69M-9.12M-6.31M-7.04M
-306.93M357.59M4.53M93.99M